HIPRA, S.A. has 16 disclosed EU lobbying meetings from 2024-10-16 to 2026-05-11: 5 with the European Commission and 11 with Members of the European Parliament. Source: EU Transparency Register no. 932962847760-35, Commission disclosures and MEP declarations. Methodology
HIPRA, S.A.
EU lobbying footprint — who they meet, and on what.
- Register no.
- 932962847760-35 ↗
- Disclosed meetings
- 16 (5 Commission · 11 MEP)
- Period
- 2024-10-16 → 2026-05-11
Declared fields of interest: Business and industry · Food safety · Public health · Research and innovation
Lobbying profile
as declared 2025-11-11- Category
- Companies & groups
- Legal status
- SOCIEDAD ANONIMA
- Declared lobbying cost
- €10,000
- Lobbying FTEs
- 1.85
- Members
- 1
At a glance
- Health1
- Technology1
- Catherine Geslain-Laneelle1
- Anne Fort1
- Joanna Drake1
- Boriša Falatar1
- Olivér Várhelyi1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- AMRsource ↗
- 2026-04-16ECCatherine Geslain-Laneelle · DirectorExchange of views on EU strategic autonomy for animal health productssource ↗
- Strengthening Europe’s Biotech and Vaccine Ecosystemsource ↗
- EU Biotech Act Isource ↗
- Biotech, One Healthsource ↗
- Politique de santé de l'UEsource ↗
- 2025-12-10ECAnne Fort · Cabinet of Commissioner Andrius KubiliusHIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic servicesource ↗
- 2025-12-08ECJoanna Drake · Deputy Director-GeneralHIPRA presentationsource ↗
- 2025-12-03ECBoriša Falatar · Cabinet of Commissioner Hadja LahbibMCM strategysource ↗
- Vaccinessource ↗
- EU vaccines and biodefence policy, DG HERAsource ↗
- Prioridades en salud públicasource ↗
- 2025-05-14ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiIntroduction of HIPRAsource ↗
- Vaccines, strategic autonomysource ↗
- Vaccines and the EU preparedness strategy to Health crisissource ↗
- Covid vaccinessource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has HIPRA, S.A. disclosed?
HIPRA, S.A. (EU Transparency Register no. 932962847760-35) appears in 16 disclosed meetings with EU officials and MEPs between 2024-10-16 and 2026-05-11: 5 with the European Commission and 11 with Members of the European Parliament.
What does HIPRA, S.A. lobby on?
HIPRA, S.A.'s disclosed EU meetings most often concern Health, Technology. Every meeting and its topic is listed with its official source on this page.
Who does HIPRA, S.A. meet in Brussels?
Across its disclosed meetings, HIPRA, S.A. has met Commission officials including Catherine Geslain-Laneelle, Anne Fort, Joanna Drake, and MEPs including GONZÁLEZ CASARES Nicolás, BOSSE Stine, VERYGA Aurelijus. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 932962847760-35) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.